1. Targeting Angiogenesis in Squamous Non-Small Cell Lung Cancer

   • Bilal Piperdi
   • Amartej Merla
   • Roman Perez-Soler

   Leading Article 28 February 2014 Pages: 403 - 413

   

2. Spleen Tyrosine Kinase Inhibitors for Rheumatoid Arthritis: Where Are We Now?

   • Ian C. Scott
   • David L. Scott

   Review Article 08 March 2014 Pages: 415 - 422

3. Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis

   • Philip J. Mease
   • April W. Armstrong

   Review Article Open access 25 February 2014 Pages: 423 - 441

   

4. Interstitial Lung Disease in Patients with Rheumatoid Arthritis: Spontaneous and Drug Induced

   • Robert W. Hallowell
   • Maureen R. Horton

   Review Article 26 February 2014 Pages: 443 - 450

5. Rivaroxaban: A Review of Its Use in Acute Coronary Syndromes

   • Greg L. Plosker

   Adis Drug Evaluation 18 February 2014 Pages: 451 - 464

6. QVA149 (Indacaterol/Glycopyrronium Fixed-Dose Combination): A Review of Its Use in Patients with Chronic Obstructive Pulmonary Disease

   • James E. Frampton

   Adis Drug Evaluation 07 March 2014 Pages: 465 - 488

7. Alemtuzumab: A Review of Its Use in Patients with Relapsing Multiple Sclerosis

   • Karly P. Garnock-Jones

   Adis Drug Evaluation 07 March 2014 Pages: 489 - 504

   

8. Tasimelteon: First Global Approval

   • Sohita Dhillon
   • Madeleine Clarke

   R&D Insight Report 08 March 2014 Pages: 505 - 511